[go: up one dir, main page]

ATE131726T1 - Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung - Google Patents

Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung

Info

Publication number
ATE131726T1
ATE131726T1 AT90916604T AT90916604T ATE131726T1 AT E131726 T1 ATE131726 T1 AT E131726T1 AT 90916604 T AT90916604 T AT 90916604T AT 90916604 T AT90916604 T AT 90916604T AT E131726 T1 ATE131726 T1 AT E131726T1
Authority
AT
Austria
Prior art keywords
hydrogel particles
erodible
production
macroporous hydrogel
active agent
Prior art date
Application number
AT90916604T
Other languages
English (en)
Inventor
Robert P Spruce Street Eury
Original Assignee
Advanced Polymer Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Polymer Systems Inc filed Critical Advanced Polymer Systems Inc
Application granted granted Critical
Publication of ATE131726T1 publication Critical patent/ATE131726T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90916604T 1989-10-03 1990-09-28 Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung ATE131726T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41656789A 1989-10-03 1989-10-03

Publications (1)

Publication Number Publication Date
ATE131726T1 true ATE131726T1 (de) 1996-01-15

Family

ID=23650468

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916604T ATE131726T1 (de) 1989-10-03 1990-09-28 Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung

Country Status (11)

Country Link
EP (1) EP0494996B1 (de)
JP (1) JP2980978B2 (de)
KR (1) KR920703016A (de)
AT (1) ATE131726T1 (de)
AU (1) AU646414B2 (de)
CA (1) CA2066594A1 (de)
DE (1) DE69024363T2 (de)
DK (1) DK0494996T3 (de)
ES (1) ES2083467T3 (de)
HK (1) HK1007109A1 (de)
WO (1) WO1991004732A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11510137A (ja) * 1995-07-28 1999-09-07 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー 植物プランクトン用の微量栄養素を含有する水−浮遊性の粒状物質
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19622355A1 (de) 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
US20030008926A1 (en) * 1997-04-30 2003-01-09 Mcpartland Tor Ant spray containing D-limonene and methods of making and using same
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US20020004502A1 (en) 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
JP2005504715A (ja) 2000-12-29 2005-02-17 アドバンスト インハレーション リサーチ，インコーポレイテッド 持続放出特性を有する吸入用粒子
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
WO2003043585A2 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
EP2389960B1 (de) 2006-06-15 2018-02-28 MicroVention, Inc. Auf umwelteinflüsse reagierendes hydrogel
JP5698537B2 (ja) 2007-12-21 2015-04-08 マイクロベンション インコーポレイテッド 生物医学的使用のためのハイドロゲルフィラメント
US8668863B2 (en) * 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
WO2010127220A2 (en) 2009-04-30 2010-11-04 Technip France Spar mooring line sharing method and system
US10639396B2 (en) 2015-06-11 2020-05-05 Microvention, Inc. Polymers
EP2493367B1 (de) 2009-10-26 2019-03-13 Microvention, Inc. Embolisierungsvorrichtung aus einem dehnbaren polymer
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
CN110433326A (zh) 2014-04-29 2019-11-12 微仙美国有限公司 包含活性剂的聚合物
CN114384227A (zh) * 2021-06-16 2022-04-22 西安石油大学 一种致密砂岩的准连续溶蚀-胶结作用致密机理测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
JP2793188B2 (ja) * 1986-08-15 1998-09-03 アドバンスト ポリマー システムズ，インコーポレイティド ポリマー担体組成物の製造方法
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates

Also Published As

Publication number Publication date
DE69024363D1 (de) 1996-02-01
DK0494996T3 (da) 1996-03-18
JPH05500959A (ja) 1993-02-25
JP2980978B2 (ja) 1999-11-22
HK1007109A1 (en) 1999-04-01
AU6715690A (en) 1991-04-28
WO1991004732A1 (en) 1991-04-18
KR920703016A (ko) 1992-12-17
EP0494996B1 (de) 1995-12-20
CA2066594A1 (en) 1991-04-04
EP0494996A1 (de) 1992-07-22
AU646414B2 (en) 1994-02-24
EP0494996A4 (en) 1992-09-30
DE69024363T2 (de) 1996-07-04
ES2083467T3 (es) 1996-04-16

Similar Documents

Publication Publication Date Title
DE69024363D1 (de) Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
DE3163877D1 (en) Membrane modified hydrogels, process for their manufacture and their use as active agent dispenser
DK164256C (da) Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf
ES2154737T3 (es) Proceso para preparar formas de dosificacion farmaceutica solidas de substancias hidrofobicas.
FI965203A0 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
PT78434B (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
NZ508470A (en) Matrices formed of polymer and hydrophobic compounds for use in sustained release drug delivery
DE69914320T2 (de) Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs
DE3863366D1 (de) Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung.
EP0145210A3 (de) Mit für biologisch aktiven Glasrohstoffen beschichtete Stützteilchen
NO953995D0 (no) Ionenolymere som anthelmintica i dyr
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
ATE93384T1 (de) Poroese mikrokugeln zur arzneistoffabgabe sowie verfahren zu deren herstellung.
ES2060791T3 (es) Composiciones cationicas para aplicacion topica.
FI950305L (fi) Perfluorialkyyliryhmiä sisältäviä fenyylisubstituoituja alkyylikarboksyylihappoguanididejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
BG103262A (en) Antimycotic gel with high degree of active substance release
ATE236621T1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
SE9604124D0 (sv) Compact member, method of manufacturing and use thereof
DE3775012D1 (de) Oberflaechenaktives mittel und verfahren zur dessen herstellung.
ES2086026T3 (es) Farmaco con efecto antineoplasico que contiene como sustancia activa (2-(n-metil-piperidino)-etil)-fosfato de octadecilo y procedimiento para su preparacion.
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
PT96828A (pt) Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee